These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4947933)

  • 21. Therapeutic effects of pentaerythritol tetranitrate in the immediate postmyocardial-infarction period.
    Mellen HS; Goldberg HS; Friedman HF
    N Engl J Med; 1967 Feb; 276(6):319-22. PubMed ID: 6016292
    [No Abstract]   [Full Text] [Related]  

  • 22. Peritrate is no longer claimed to aid survival.
    Drug Ther Bull; 1966 Jun; 4(12):47-8. PubMed ID: 5947207
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pentaerythritol tetranitrate effects on electrocardiographic changes induced by glucose loading].
    Ferlito S; Bonaventura S
    Policlinico Med; 1971; 78(6):252-62. PubMed ID: 5157399
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged].
    Gatti A; Scotti G
    Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306
    [No Abstract]   [Full Text] [Related]  

  • 25. [Analysis of the systolic phase of the left ventricle in assessing the efficacy of therapy of patients with chronic coronary insufficiency].
    Shmeleva NK
    Ter Arkh; 1966 Sep; 38(9):77-81. PubMed ID: 4385082
    [No Abstract]   [Full Text] [Related]  

  • 26. [Differential treatment of coronary heart disease].
    Weser C; Scheidler K
    Z Arztl Fortbild (Jena); 1974 Jul; 68(13):647-53. PubMed ID: 4216180
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical experience with the association of a beta-blocking agent and pentaerythrite].
    Barbi G; Tallone G
    Minerva Cardioangiol; 1969 Feb; 17(2):139-41. PubMed ID: 5777637
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experience with the coronary therapeutic agent STENO-Tromcardin in the general practice].
    Jaschke J
    Med Welt; 1969 Mar; 13():744-6. PubMed ID: 5784357
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the objective evaluation of the effects of coronary vasoactive drugs].
    Lenti G; Cherchi A; Raffo M; Porrazzo G
    Minerva Med; 1966 Feb; 57(12):455-9. PubMed ID: 5910815
    [No Abstract]   [Full Text] [Related]  

  • 30. [Coronary therapy with Nitro-Sandolanid].
    Toker Y
    Munch Med Wochenschr; 1970 Apr; 112(17):809-12. PubMed ID: 5467991
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the circulatory effect of the coronary dilator PETN].
    Tilsner V
    Med Klin; 1969 Jun; 64(24):1120-3. PubMed ID: 5809489
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy and prevention of ischemic heart diseases].
    Gill E
    Z Allgemeinmed; 1973 Oct; 49(28):1354-6. PubMed ID: 4756675
    [No Abstract]   [Full Text] [Related]  

  • 33. [The combination preparation VisanoCor in patients with angina pectoris with special monitoring of urinary catecholamines].
    Hagel H
    Fortschr Med; 1981 Nov; 99(41):1714-7. PubMed ID: 7319440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of pentaerithrol and raupasil on nasal patency].
    Kubiak S; Hauslinger J
    Pol Tyg Lek; 1977 Jan; 32(2):57-9. PubMed ID: 834635
    [No Abstract]   [Full Text] [Related]  

  • 35. The difficulty of appraisal of streptokinase treatment of myocardial infarction.
    Verstraete M
    Angiologica; 1971; 8(1):43-56. PubMed ID: 4939595
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical experience with intravenous infusion of nitroglycerin in myocardial infarction and acute coronary failure].
    Aleksandrow D; Aleksandrow W; Dyduszyński A; Wiernikowski A
    Kardiol Pol; 1982; 25(10-11):821-8. PubMed ID: 6820808
    [No Abstract]   [Full Text] [Related]  

  • 37. [Conservative therapy of angina pectoris].
    Nager F
    Schweiz Med Wochenschr; 1970 May; 100(20):855-61. PubMed ID: 4997632
    [No Abstract]   [Full Text] [Related]  

  • 38. [Combined treatment of chronic coronary disease with pentaerythritol tetranitrate and propranolol].
    Florkiewicz H; Rymar B; Markiewicz M; Trojnar R; Rumiński W
    Pol Tyg Lek; 1981 Apr; 36(14):501-3. PubMed ID: 7267422
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical use of the butydrine-pentaetythrite association].
    Ravera M
    Minerva Med; 1968 Oct; 59(86):4561-5. PubMed ID: 5697129
    [No Abstract]   [Full Text] [Related]  

  • 40. [Coronary therapy in geriatrics].
    Grübl M; Klein K; Siedek H
    Wien Med Wochenschr; 1973 Dec; 123(50):741-5. PubMed ID: 4763134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.